
Rainier Acquisition Prices $75 Million Life Sciences SPAC IPO
Special purpose acquisition company Rainier Acquisition has priced its initial public offering at $75 million on the Nasdaq exchange. The newly listed entity will focus on identifying and merging with companies in the life sciences sector.
The Story
Analyzing sources…


